Non conventional virological markers in HIV-infected patients: T-HIV DNA, 2LTR-HIV DNA and HIV RNA;Marcadores virologicos no convencionales en pacientes infectados con el virus de la inmunodeficiencia humana: ADN HIV-T, ADN HIV-2LTR y ARN de HIV

Medicina

Volumn 64, Issue 5, 2004, Pages 419-428

  Gariglio, Rosana ^a   Taborda, Miguel A ^b   Bortolozzi, Raul ^c   McDermott, Jennifer L ^d   Martini, Isabella ^d   Borgognone, Mariana ^a   Villanova, G Vanina ^b   Varnier, Oliviero E ^d   Giri, Adriana A ^b,e  

^a SCIENCE APPLICATIONS INTERNATIONAL CORPORATION   (United States)

^b UNIVERSIDAD NACIONAL DE ROSARIO   (Argentina)

^c Hospital de Día   (Argentina)

^d UNIVERSITY OF GENOA   (Italy)

^e Instituto de Biologia Molecular y Celular de Rosario   (Argentina)

Author keywords

Human immunodeficiency virus; PCR with colorimetric detection; Virological markers

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; RITONAVIR; SAQUINAVIR; STAVUDINE; VIRUS DNA; VIRUS RNA; ZIDOVUDINE; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; BIOLOGICAL MARKER;

ADULT; ARGENTINA; ARTICLE; COLORIMETRY; CONTROLLED STUDY; FEMALE; GENETIC HETEROGENEITY; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INFECTION CONTROL; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SENSITIVITY ANALYSIS; VIREMIA; VIROLOGY; BLOOD; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; DRUG EFFECT; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; MIDDLE AGED; VIRUS LOAD; VIRUS REPLICATION;

ADULT; ANTI-HIV AGENTS; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; BIOLOGICAL MARKERS; BRANCHED DNA SIGNAL AMPLIFICATION ASSAY; DNA, VIRAL; FEMALE; HIV INFECTIONS; HIV LONG TERMINAL REPEAT; HIV-1; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 9744283510     PISSN: 00257680     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Perelson AS, Essunger P, Cao Y, et al. Decay characteristics of HIV-1 infected compartments during combination therapy. Nature 1997; 387: 188-91.
2. Gulick RM, Mellors JW, Havlir D, et al. Treatment with indinavir, zidovudine, and lamivudine in adults with human immunodeficiency virus infection and prior antiretroviral therapy. N Engl J Med 1997; 337: 734-9.
3. Clementi M, Menzo S, Bagnarelli P, et al. Clinical use of quantitative molecular methods in studying human immunodeficiency virus type 1 infection. Clin Microbiol Rev 1996; 9: 135-47.
4. Lew J, Reichelderfer P, Fowler M, et al. Determinations of levels of human immunodeficiency virus type 1 RNA in plasma: reassessment of parameters affecting assay outcome. TUBE Meeting Workshop Attendees. Technology Utilization for HIV-1 Blood Evaluation and Standardization in Pediatrics. J Clin Microbiol 1998; 36: 1471-9.
5. Powderly WG, Saag MS, Chapman S, Yu G, Quart B, Clendeninn NJ. Predictors of optimal virological response to potent antiretroviral therapy. AIDS 1999; 13: 1873-80.
6. Finzi D, Hermankova M, Pierson T, et al. Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy. Science 1997; 278: 1295-300.
7. Wong JK, Hezareh M, Gunthard HF, et al. Recovery of replication-competent HIV despite prolonged suppression of plasma viremia. Science 1997; 278: 1291-5.
8. Ramratnam B, Mittler JE, Zhang L, et al. The decay of the latent reservoir of replication-competent HIV-1 is inversely correlated with the extent of residual viral replication during prolonged anti-retroviral therapy. Nat Med 2000; 6: 82-5.
9. Flint SJ, Enquist LW, Krug RM, Racaniello VR, Skalka AM (ed.), Principles of Virology: Molecular Biology, Pathogenesis and Control, Washington DC (USA): ASM Press, 2000, pp 631-61.
10. McDermott JL, Giri AA, Martini I, et al. HIV DNA in peripheral blood mononuclear cells correlates with antiretroviral therapy efficacy. J Clin Microbiol 1999; 37: 2361-5.
11. Sharkey ME, Teo I, Greenough T, et al. Persistence of episomal HIV-1 infection intermediates in patients on highly active anti-retroviral therapy. Nat Med 2000; 6: 76-81.
12. Suzuki K, Okamoto N, Watambe S, Kano T. Chemiluminescent microtiter method for detecting PCR amplified HIV-1 DNA. J Virol 1992; 38: 113-22.
13. Christopherson C, Kidane Y, Conway B, Krowka J, Sheppard H, Kwok S. PCR-Based Assay to quantify Human Immunodeficiency Virus Type 1 DNA in Peripheral Blood Mononuclear Cells. J Clin Microbiol 2000; 38: 630-4.
14. De Milito A, Titanji K, Zazzi M. Surrogate markers as a guide to evaluate response to antiretroviral therapy. Curr Med Chem 2003; 10: 349-65.
15. Varmus HE, Swanstrom R. Replication of retroviruses. In Weiss R, Brown N, Teich N, Coffin J. (ed.), RNA tumor viruses, NY (USA): Cold Spring Harbor, 1984 pp 75-134.
16. Brown PO, Bowerman B, Varmus HE, Bishop JM, Bishop JM. Correct integration of retroviral DNA in vitro. Cell 1987; 49: 347-57.
17. Cara A and Reitz MS Jr, New insights on the role of extrachromosomal forms of retroviral DNA. Leukemia 1997; 11: 1395-9.
18. Giri AA, McDermott JL, Martini I, Bertolotti F, Musolino B, Varnier OE. Unintegrated 2LTR HIV DNA as a marker of therapy inefficacy in aviremic patients under HAART. The 1st IAS Conference on HIV Pathogenesis and Treatment, Buenos Aires (Argentina), 8-11/07/2001, Abs. LB-P7, p. 326.
19. CDC 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Recomm Rep. 1992; 41: 1-19.
20. Gallant JE. Treatment strategies for the antiretroviral-experienced patient. Posted on 08/28/2002 in http://www.medscape.com/viewarticle/440611.
21. Yeni PG, Hammer SM, Carpenter CC, et al. Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society-USA Panel. JAMA 2002; 288: 222-35.
22. Giri AA, Lillo FB, McDermott JL, et al. Detection of HIV sequences in children using radioactive and colorimetric polymerase chain reactions. J Med Virol 1994;42:414-9.
23. Saiki Rk, Bugawan TL, Horn GR, Mullis KB, Erlich HA: Analysis of enzymatically amplified β-globin and HLA DNA with allele-specific oligonucleotide probes. Nature 1986;324:163-6.
24. Kellogg DE, Kwok S. Detection of human Immunodeficiency virus. In: Innis MA, Gelfand DH, Sninsky JJ, White TJ (eds). PCR Protocols: a guide to methods and applications. San Diego: Academic Press, 1990:337-47.
25. Giacomini M, Mc Dermott JL, Giri AA, Martini I, Lillo FB, Varnier OE: A novel and innovative quantitative kinetic software for virological colorimetric assays. J Virol Meth. 1998; 73: 201-9.
26. Butler SL, Johnson EP, FD Bushman. Human immunodeficiency virus cDNA metabolism: notable stability of two-long terminal repeat circles. J Virol 2002; 76: 3739-47.
27. Pierson TC, Kieffer TL, Ruff CT, Buck C, Gange SJ, Siliciano RF. Intrinsic stability of episomal circles formed during human immunodeficiency virus type 1 replication. J Virol 2002; 76: 4138-44.
28. Cara A, Vargas J Jr, Keller M, et al. Circular viral DNA and anomalous junction sequence in PBMC of HIV-infected individuals with no detectable plasma HIV RNA. Virology 2002; 292: 1-5.